Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Perrigo Company ( (PRGO) ).
On April 30, 2026, Perrigo Company plc held its 2026 Annual General Meeting of Shareholders, at which shareholders elected all nominated directors to serve until the 2027 meeting, with each candidate receiving strong majority support. Shareholders also approved, on an advisory basis, the company’s executive compensation program and ratified Ernst & Young LLP as independent auditor for the year ending December 31, 2026.
Investors backed Perrigo’s 2026 equity compensation plan and renewed the Board’s authority under Irish law both to issue shares and to opt out of statutory pre-emption rights, signaling broad support for the company’s capital structure flexibility and governance framework. The voting outcomes collectively reinforce management’s strategic latitude and confirm continued shareholder confidence in Perrigo’s leadership and oversight.
The most recent analyst rating on (PRGO) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Perrigo Company stock, see the PRGO Stock Forecast page.
Spark’s Take on PRGO Stock
According to Spark, TipRanks’ AI Analyst, PRGO is a Neutral.
PRGO scores weak-to-midrange primarily due to deteriorating profitability and declining revenue trends, despite positive cash generation and reduced balance-sheet leverage. Technicals are strongly bearish with the stock trading below key moving averages and negative momentum indicators. Guidance suggests a challenging 2026 transition year with notable near-term EPS headwinds and impairment risk, while the very high dividend yield and extended revolver maturity provide partial support.
To see Spark’s full report on PRGO stock, click here.
More about Perrigo Company
Perrigo Company plc is a healthcare manufacturer focused on consumer self-care products, including over-the-counter medicines and related health solutions. The company targets retail and pharmacy customers with branded and private-label offerings, positioning itself as a key player in the consumer health and wellness market.
Average Trading Volume: 3,275,239
Technical Sentiment Signal: Sell
Current Market Cap: $1.57B
See more insights into PRGO stock on TipRanks’ Stock Analysis page.